The cellular response to a lack of oxygen is largely dependent on the activation of hypoxia-inducible transcription factors (HIF). Upon hypoxia, stabilization of these factors and execution of their transcriptional program induces a metabolic adaptation to low oxygen levels, which is required for organ physiology.
This programme is of special importance in the kidney taking into account the low intra-parenchymal oxygen pressure in combination with energy-demanding transport processes in renal epithelial cells. Consequently, it is not surprising that an activation of hypoxia signalling can also protect from acute kidney injury by increasing cellular stress resistance.
The concept of hypoxic preconditioning can be mediated either by direct pharmacological activation of HIF or exposure to low oxygen pressure and is actively studied as a novel tool to prevent acute kidney injury in the clinical setting. However, induction of HIF-signaling is also the key process underlying the pathogenesis of renal cell carcinoma indicating that stress resistance and tumorigenesis are closely related cellular states.
In this project, we combine models of hypoxic preconditioning in mouse and nematode with genetic models of multitumor syndromes associated with renal cell carcinoma (e.g. Von-Hippel-Lindau syndrome, Birt-Hogg-Dube syndrome) to elucidate the mechanistic role of hypoxia signalling. Using these models in combination with state-of-the-art molecular biology we focus on the mechanistic role of RNA-protein interactions involved in cellular stress resistance.
Acute kidney injury (AKI) is one of the most frequent complications in hospitalized patients and its incidence is rising alongside the demographic changes of our society. AKI is strongly associated with worse clinical outcome including mortality and chronic kidney disease. Despite the clear clinical importance, there are no measures available to treat or prevent AKI in a targeted fashion. A detailed understanding of pathways mediating renal organ protection is urgently required to develop novel approaches to prevent AKI and its consequences.
Clinic II of Internal Medicine
CMMC - PI - assoc. RG 13
roman-ulrich.mueller[at]uk-koeln.de
show more…+49 221 478 89033
+49 221 478 89041
Clinic II of Internal Medicine
Kerpener Str. 62
50937 Cologne
Sita Arjune
Katrin Bohl
Reza Esmaillie
Samantha Filipow
Serena Greco-Torres
Johanna Hoyer-Allo
Michael Ignarski
Felix Köhler
Francisco Lopes
Pedro Rojas Morales
Willian Salgueiro
Lisa Seufert
Martin Späth